https://orcid.org/0000-0002-4424-4491
References
- Ursin RL, Klein SL. Sex differences in respiratory viral pathogenesis and treatments. Annu Rev Virol [Internet]. 2021;8:393–3. [accessed 2021 Jul 2]. https://www.annualreviews.org/doi/10.1146/annurev-virology-091919-092720 .
- Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;209:114–19. doi:10.1093/infdis/jiu066.
- Aaby P, Benn CS, Flanagan KL, Klein SL, Kollmann TR, Lynn DJ, Shann F. The non-specific and sex-differential effects of vaccines. Nat Rev Immunol. 2020;20:464–70. doi:10.1038/s41577-020-0338-x.
- Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol. 2017;33:577–99. doi:10.1146/annurev-cellbio-100616-060718.
- Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020;11:32. doi:10.1186/s13293-020-00308-5.
- Heidari S, Durrheim DN, Faden R, Kochhar S, MacDonald N, Olayinka F, Goodman TS. Time for action: towards an intersectional gender approach to COVID-19 vaccine development and deployment that leaves no one behind. BMJ Global Health. 2021;6:e006854. doi:10.1136/bmjgh-2021-006854.
- Evagora-Campbell M, Borkotoky K, Sharma S, and Mbuthia M. From routine data collection to policy design: sex and gender both matter in COVID-19. The Lancet. 2021;397(10293):2447–2449. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01326-X/fulltext .
- SDG3 Global Action Plan for Healthy Lives and Well-Being: Gender Equality Working Group, Gender and Health Hub, United Nations University International Institute for Global Health. Guidance note and checklist for tackling gender-related barriers to equitable COVID-19 vaccine deployment [Internet]. 2021 [accessed 2021 Apr 21]. https://www.genderhealthhub.org/articles/guidance-note-and-checklist-for-tackling-gender-related-barriers-to-equitable-covid-19-vaccine-deployment/ .
- Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, and Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;1–10. https://globalhealth5050.org/the-sex-gender-and-covid-19-project/the-data-tracker/?explore=variable .
- Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, Wu JW. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol. 2021;36:197–211. doi:10.1007/s10654-021-00728-6.
- Global Health 50/50. The COVID-19 sex-disaggregated data tracker: vaccinations-at least one dose [Internet]; 2021. https://globalhealth5050.org/the-sex-gender-and-covid-19-project/the-data-tracker/?explore=variable&variable=Vaccinations. Accessed on 30 June 2021.
- Heidari S, Palmer-Ross A, Goodman T. A systematic review of the sex and gender reporting in COVID-19 clinical trials. Vaccines. 2021;9:1322. doi:10.3390/vaccines9111322.
- Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and gender equity in research: rationale for the SAGER guidelines and recommended use. Res Integrity Peer Rev. 2016;1:2. doi:10.1186/s41073-016-0007-6.
- Palmer-Ross A, Ovseiko PV, Heidari S. Inadequate reporting of COVID-19 clinical studies: a renewed rationale for the sex and gender equity in research (SAGER) guidelines. BMJ Glob Health. 2021;6:e004997. doi:10.1136/bmjgh-2021-004997.
- Fenwick E, Steuten L, Knies S, Ghabri S, Basu A, Murray JF, Koffijberg (Erik) H, Strong M, Schmidler GDS, Rothery C. Value of information analysis for research decisions—an introduction: report 1 of the ISPOR value of information analysis emerging good practices task force. Value Health. 2020;23:139–50. doi:10.1016/j.jval.2020.01.001.
- Heidari S, and Goodman T. Critical sex and gender considerations for equitable research, development and delivery of COVID-19 vaccines: background paper [Internet]; 2021. https://cdn.who.int/media/docs/default-source/immunization/sage/covid/gender-covid-19-vaccines-sage-background-paper.pdf?sfvrsn=899e8fca_15&download=true. Accessed on 10 August 2021.
- Ravindran SK, Teerawattananon Y, Tannenbaum C, and Vijayasingham L. Making pharmaceutical research and regulation work for women. Br Med J. 2020;371:1–5. doi:10.1136/bmj.m3808.
- Turner MA, Catapano M, Hirschfeld S, Giaquinto C. Paediatric drug development: the impact of evolving regulations. Adv Drug Deliv Rev. 2014;73:2–13. doi:10.1016/j.addr.2014.02.003.